Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
Apply
Selumetinib & DS-8201a
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step